Lynza 150mg Olaparib Tablet

Lynza 150mg Olaparib Tablet is a prescription targeted anti-cancer medication used in the treatment of certain BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. It contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor that works by blocking the ability of cancer cells to repair damaged DNA, leading to cell death and helping to slow disease progression. Lynza 150mg Tablet is often prescribed as maintenance therapy or as part of a comprehensive cancer treatment plan for eligible patients. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to evaluate treatment response and manage potential side effects. Patients should use Lynza 150mg Olaparib Tablet only as directed by their healthcare provider and attend all scheduled follow-up appointments during therapy.